Adalimumab/azathioprine/infliximabMalignant melanoma: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2014年 / 1532卷 / 1期

关键词：

D O I：

10.1007/s40278-014-5827-x

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：16 / 16

相关论文

共 50 条

[31] Adalimumab/azathioprine/infliximabMultiple toxicities: 6 case reports
Reactions Weekly, 2022, 1923 (1) : 21 - 21
[32] Adalimumab/azathioprine/infliximab/methotrexateTuberculosis: 7 case reports
Reactions Weekly, 2015, 1538 (1) : 15 - 15
[33] Adalimumab/azathioprine/mesalazineCytomegalovirus primoinfection: 2 case reports
Reactions Weekly, 2019, 1770 (1) : 21 - 21
[34] Adalimumab/azathioprine/infliximabVarious toxicities: 11 case reports
Reactions Weekly, 2014, 1524 (1) : 15 - 15
[35] Adalimumab/azathioprine/infliximabReactivation of TB: 4 case reports
Reactions Weekly, 2019, 1762 (1) : 17 - 17
[36] Adalimumab/azathioprine/infliximabDiffuse large B-cell lymphoma stage III: case report
Reactions Weekly, 2023, 1972 (1) : 21 - 21
[37] Adalimumab/azathioprine/infliximabAcute myeloid leukaemia with myelodysplasia-related changes and febrile neutropenia: case report
Reactions Weekly, 2019, 1737 (1) : 15 - 15
[38] Adalimumab/mercaptopurineDisseminated coccidioidomycosis (first report for adalimumab): case report
Reactions Weekly, 2010, 1304 (1) : 7 - 7
[39] Azathioprine/ciclosporinNeutropenia: case report
Reactions Weekly, 2016, 1630 (1) : 29 - 29
[40] Azathioprine/prednisoloneChromoblastomycosis: case report
Reactions Weekly, 2012, 1384 (1) : 10 - 10

← 1 2 3 4 5 →